mock treatment CLTA, EMX, and VEGF genomic sites from 5/13/14
Sequencing from Zuris et al. Nature Biotechnology 2014.  Three new target sites (sites CLTA, EMX, and VEGF) were chosen in the human genome that each had potential genomic off-target sites containing one identical or nearly identical half-site.  The three on-target sites and their highly similar off-target sites were amplified and sequenced from Hek293 cells treated with a mock transfection of a GFP expression plasmid.  All genomic target sites (for CLTA, EMX and VEGF) were combined together for each type of treatment.